et ary ▁name : ▁y tt rium ▁( 9 0 Y ) ▁ed ot re ot ide ) ▁is ▁designated ▁as ▁an ▁or phan ▁drug ▁but ▁has ▁not ▁yet ▁received ▁market ing ▁author isation . ▁ ▁United ▁Kingdom ▁In ▁guidance ▁published ▁in ▁August ▁ 2 0 1 8 , ▁lut et ium ▁( 1 7 7 Lu ) ▁ox odot re ot ide ▁was ▁recommended ▁by ▁N ICE ▁for ▁tre ating ▁un res ect able ▁or ▁met ast atic ▁ne uro end ocr ine ▁tum ours . ▁ ▁Australia ▁Research ▁in ▁Australia ▁into ▁the ▁use ▁of ▁lut et ium - 1 7 7 - label led ▁ant ib od ies ▁for ▁various ▁can cers ▁began ▁in ▁the ▁Department ▁of ▁N uc lear ▁Medicine ▁at ▁F rem ant le ▁Hospital ▁and ▁Health ▁Service ▁( F H HS ), ▁F rem ant le , ▁Australia ▁in ▁the ▁late ▁ 1 9 9 0 s . ▁ ▁The ▁first ▁ther ap ies ▁in ▁Australia ▁using ▁ 1 7 7 Lu - D OT AT ATE ▁PR RT ▁for ▁N ET ▁began ▁in ▁February ▁ 2 0 0 5 ▁on ▁a ▁trial ▁basis ▁under ▁the ▁Th era pe ut ic ▁Good s ▁Administration ' s ▁( T GA ) ▁Special ▁Access ▁Sch eme ▁( S AS ) ▁and ▁comp ass ion ate ▁usage ▁of ▁un appro ved ▁th era pe ut ic ▁goods . ▁Short ly ▁after ▁this , ▁ 1 7 7 Lu - D OT AT ATE ▁PR RT ▁was ▁provided ▁to ▁Western ▁Australian ▁N